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Abstract
Objective
To provide recommendations for the routine management of pediatric patients that present with signs
concerning for laryngomalacia.
Study Design
Expert opinion by the members of the International Pediatric Otolaryngology Group (IPOG).
Results
Consensus recommendations include evaluation and treatment considerations for commonly debated
issues in laryngomalacia, initial work-up of those patients presenting with inspiratory stridor, treatment
recommendations based on disease severity, management of the infant with feeding difficulties, postsurgical treatment management recommendations, and suggestions for acid suppression therapy. These
recommendations are based on the collective opinion of the IPOG members and are targeted to primary
care practitioners, otolaryngologists, and other health care providers who commonly evaluate pediatric
patients with noisy breathing.
Conclusion
Laryngomalacia care consensus recommendations are aimed at improving patient-centered care in
infants with laryngomalacia.
Level of evidence: 5
Keywords: laryngomalacia, infant, stridor, pediatric
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International Pediatric ORL Group (IPOG)

Laryngomalacia Consensus Recommendations
Consensus Objectives
To provide recommendations for the routine management of pediatric patients that present with signs
concerning for laryngomalacia.
Target Population
Pediatric patients with signs concerning for laryngomalacia.
Intended Users
These consensus recommendations are targeted for:
1. Primary care practitioners, otolaryngologists, and other health care providers who commonly
evaluate pediatric patients with noisy breathing.
Recommendations and Justification
The recommendations are outlined in the following appendices
 Section 1: Evaluation and treatment considerations
 Section 2: Initial presentation algorithm
 Section 3: Comprehensive care algorithm
 Section 4: Management of the difficult to feed infant with laryngomalacia
 Section 5: Post-surgical treatment algorithm
 Section 6: Recommendations for acid suppression therapy
Disclaimer
Members of the International Pediatric ORL Group (IPOG) prepared this report. Consensus
recommendations are based on the collective opinion of the members of this group. Any person seeking
to apply or consult the report is expected to use independent medical judgment in the context of
individual patient and institutional circumstances.
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Section 1: Evaluation and treatment considerations
The members of the IPOG identified five frequently debated evaluation and treatment considerations in
the management of laryngomalacia. Variation in practice among the current group members remains,
and the purpose of this section is to provide a list of reasonable options based on expert opinion. Table
1.
Table 1.
Question
1. What findings on initial
presentation should prompt a
more urgent evaluation by an
otolaryngologist?

2.

Should I treat laryngomalacia
empirically with acid
suppression?













3.

Should I formally assess the
infant’s swallow?








4.

What other consultations
should I consider for the infant
with severe disease?









5.

What assessment should be
done for persistent symptoms
after supraglottoplasty?




Apnea
Tachypnea
Cyanosis
Failure to thrive
Difficult to feed despite acid suppression/texture modification
Aspiration/pneumonia
Cor pulmonale
Yes, if child having feeding and/or respiratory difficulties
Consider observation in those infants with mild respiratory
symptoms and are gaining weight appropriately
Can use either step-up or step-down methodology (see Section 6)
Recommend weaning acid suppression based on symptoms vs.
stopping abruptly
Consider GI referral for concurrent management
Consider feeding/swallow evaluation and diet modification
in cases where there is cough, choking, regurgitation, feeding
difficulty, no weight gain, or failure to thrive
Strongly consider evaluation in children with evidence of aspiration
or those with neurologic disease
Consider evaluation by either/both video fluoroscopic swallow study
(VFSS) and/or fiberoptic endoscopic evaluation of swallowing (FEES).
Assessment in conjunction with feeding therapy may aid diagnostic
accuracy and feeding recommendations
Consider acid suppression in patients with laryngeal penetration
and/or aspiration on swallow evaluation
Pulmonary evaluation if disease on imaging or symptoms of
asthma/reactive airway disease
Consider polysomnography or home oximetry monitoring if
significant apnea
Cardiac consultation if heart disease suspected
Possible GI evaluation if refractory to acid suppression therapy
Neurology and/or brain MRI if neurologic disease suspected (i.e.
physical findings of hypotonia, pooled/frothy secretions on
endoscopy)
Genetics evaluation for those with craniofacial dysmorphism or
severe disease
Craniofacial team evaluation for those with craniofacial anomalies
Suggestions include:
 Consider aerodigestive evaluation including pH/impedance
probe to rule out persistent reflux, esophageal biopsies to rule
out eosinophilic esophagitis, pulmonary evaluation to optimize
respiratory function
 Consider gastrostomy tube and/or fundoplication for patients
with esophageal reflux not managed on maximal medical
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therapy
Consider polysomnography in patients with oxygen
desaturations or signs of apnea
Consider neurology and/or MRI brain if neurologic disease
suspected
Consider tracheostomy in patients with multiple comorbidities or synchronous airway lesions

Section 2: Initial presentation algorithm
The initial presentation algorithm is designed to guide the initial evaluation of the infant presenting with
inspiratory stridor. This may vary depending on what type of medical care setting the infant presents in.
Flexible fibertoptic laryngoscopy (FFL) is important to confirm the diagnosis. Urgency of referral to an
otolaryngologist is guided by severity of disease. Those with more severe disease may warrant
expedited referral and those who have significant apnea/desaturations and/or inability to feed may
warrant inpatient admission. Those infants who may be aspirating and/or have pulmonary disease may
benefit from chest x-ray to further evaluate this. Those infants whose laryngoscopy findings are not
commensurate with the severity of their symptoms may benefit from airway films to screen for a
secondary airway lesion. Further recommendations are detailed in Figure 1.
Figure 1. Initial presentation algorithm
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Section 3: Comprehensive care algorithm
The algorithm in Figure 2 was designed to guide treatment for the infant that has been diagnosed with
laryngomalacia, confirmed by FFL. This algorithm stratifies management decisions based on disease
severity. The group suggests that the provider should recognize the presence of co-morbidities (see
figure 2) that may lead to sub-optimal outcomes. Additionally, supraglottoplasty should be carefully
considered in those with neurologic disease whose aspiration could be made worse by surgery.
Variation in practice among the current group members remains, and the purpose of this section is to
provide a list of reasonable options based on expert opinion.
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Section 4: Management of the difficult to feed infant with laryngomalacia
This algorithm in Figure 3 outlines a guide for managing infants who have been diagnosed with
laryngomalacia and are having difficulty with effectively and/or safely feeding. The algorithm may be
best performed in conjunction with feeding or speech therapy services when available to guide feeding
recommendations and therapy. Chest x-ray may be indicated in the infant if there are signs of
respiratory compromise. Again, variation in practice among the current group members remains, and
the purpose of this section is to provide a list of reasonable options based on expert opinion.
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Section 5: Post-surgical treatment algorithm and persistent laryngomalacia
The algorithm displayed in Figure 4 is intended to guide management in infants whom have undergone
supraglottoplasty and is targeted towards those who have persistent laryngomalacia despite surgery.
Time course for follow-up is variable amongst providers and is dictated by the severity of persistent
symptoms in the patient. Persistent laryngopharyngeal reflux or undiagnosed eosinophilic esophagitis
may drive persistent laryngeal edema leading to continued laryngomalacia. Confirming the presence or
absence of obstructive sleep apnea may drive decision making towards surgical management vs.
observation. Lastly, identifying and optimizing cardiac, neurologic, and pulmonary co-morbidities is
paramount in managing the infant with persistent symptoms after supraglottoplasty, especially before
considering revision surgery. Again, variation in practice among the current group members remains,
and the purpose of this section is to provide a list of reasonable options based on expert opinion.

IPOG Pediatric Laryngomalacia Consensus Recommendations 9

Section 6: Recommendations for acid suppression therapy
Figure 5 provides a “step-up” vs. a “step-down” regimen for managing acid suppression therapy. In a
“step down” regimen, therapy can be started with both a proton pump inhibitor (PPI) and a histamine-2
blocker (H2RA) and then weaned to a single therapy if the patient improves. Conversely, the infant can
be started conservatively on a single therapy and “stepped-up” to dual acid suppression if symptoms are
not controlled. We suggest maintaining therapy for at least 3 months after initiation and a wean should
not be considered until a diet can be safely tolerated from an aspiration standpoint. Consider
gastroenterology evaluation and/or pH/impedance probe testing in those that are refractory to therapy.
Additionally, erythromycin ethylsuccinate (Eryped) can be considered to improve gastrointestinal
motility in refractory cases. There was great variation in practice among the current group members,
and the purpose of this section is to provide reasonable options to guide the practitioner when using
acid suppression in the setting of laryngomalacia.
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